Search
for
Sort by
Research 31–60 of 1000+
- Drug-Induced Hair Changes
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- DRUG‐ASSOCIATED ALOPECIA
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Difficult and rare forms of acne
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Adverse Cutaneous Reactions to Mood Stabilizers
- Nanotechnology-based techniques for hair follicle regeneration
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Nanocarrier Systems for Transdermal Drug Delivery
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Benign Cutaneous Eruptions After Transplantation
- Chemotherapy and Cutaneous Drug Reactions
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- Dermatologic Adverse Events from Cancer Treatments
- Efectos adversos dermatológicos con uso de litio
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Dermatologic Reactions to Targeted Therapy